![Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-018-02517-1/MediaObjects/428_2018_2517_Fig2_HTML.png)
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink
![PDF) Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma PDF) Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma](https://i1.rgstatic.net/publication/348601967_Neuropilin_1_and_Neuropilin_2_gene_invalidation_or_pharmacological_inhibition_reveals_their_relevance_for_the_treatment_of_metastatic_renal_cell_carcinoma/links/6015e2d4a6fdcc071ba4dc9e/largepreview.png)
PDF) Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
![Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney ... Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41379-018-0017-7/MediaObjects/41379_2018_17_Fig1_HTML.jpg)
Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney ...
![SciELO - Brasil - Epidemiologic characteristics of renal cell carcinoma in Brazil Epidemiologic characteristics of renal cell carcinoma in Brazil SciELO - Brasil - Epidemiologic characteristics of renal cell carcinoma in Brazil Epidemiologic characteristics of renal cell carcinoma in Brazil](https://minio.scielo.br/documentstore/1677-6119/wZjhY9JzNWDxLYpcsx4Z99K/9fd0ef76011005f691d6f0f2d928dd8851416dd1.gif)
SciELO - Brasil - Epidemiologic characteristics of renal cell carcinoma in Brazil Epidemiologic characteristics of renal cell carcinoma in Brazil
![Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents - Cancer Treatment Reviews Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/35cd8248-fa59-4432-a170-e9dc6a83fda4/gr1_lrg.jpg)
Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents - Cancer Treatment Reviews
![Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3f1cbaf5-e5e9-48ca-9806-261b3a514a07/cge13014-fig-0004-m.jpg)
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library
![PDF) RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs PDF) RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs](https://i1.rgstatic.net/publication/283494169_RANKOPG_ratio_of_expression_in_primary_clear-cell_renal_cell_carcinoma_is_associated_with_bone_metastasis_and_prognosis_in_patients_treated_with_anti-VEGFR-TKIs/links/5a0c1304458515e482751842/largepreview.png)
PDF) RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
![Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol | Nature Reviews Urology Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol | Nature Reviews Urology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrurol.2017.163/MediaObjects/41585_2017_Article_BFnrurol2017163_Fig1_HTML.jpg)
Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol | Nature Reviews Urology
![Frontiers | Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence | Endocrinology Frontiers | Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence | Endocrinology](https://www.frontiersin.org/files/MyHome%20Article%20Library/485622/485622_Thumb_400.jpg)
Frontiers | Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence | Endocrinology
![PDF) Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients PDF) Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients](https://i1.rgstatic.net/publication/24191454_Sunitinib_Mediates_Reversal_of_Myeloid-Derived_Suppressor_Cell_Accumulation_in_Renal_Cell_Carcinoma_Patients/links/0046352a756c062940000000/largepreview.png)
PDF) Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
![Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1476-4598-12-140/MediaObjects/12943_2013_Article_1196_Fig3_HTML.jpg)
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text
![Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d80e5633-07b6-4c6c-84aa-6817fa5f1a16/cge13014-fig-0001-m.jpg)
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library
![PDF) Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 PDF) Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3](https://i1.rgstatic.net/publication/49658682_Genome-wide_association_study_of_renal_cell_carcinoma_identifies_two_susceptibility_loci_on_2p21_and_11q133/links/0912f4fbe395a97e22000000/largepreview.png)
PDF) Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
![Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1476-4598-12-140/MediaObjects/12943_2013_Article_1196_Fig2_HTML.jpg)
Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations | Molecular Cancer | Full Text
![Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3511368c-c525-4c0a-bf7e-79e5b33e9a4d/cge13014-fig-0002-m.jpg)
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers - Muller - 2017 - Clinical Genetics - Wiley Online Library
![Frontiers | Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors | Immunology Frontiers | Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors | Immunology](https://www.frontiersin.org/files/Articles/521735/fimmu-11-00783-HTML-r1/image_m/fimmu-11-00783-g001.jpg)
Frontiers | Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors | Immunology
![Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-018-02517-1/MediaObjects/428_2018_2517_Fig1_HTML.png)
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology | SpringerLink
![Approaches to treat immune hot, altered and cold tumours with combination immunotherapies | Nature Reviews Drug Discovery Approaches to treat immune hot, altered and cold tumours with combination immunotherapies | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41573-018-0007-y/MediaObjects/41573_2018_7_Fig1_HTML.png)